Fidelity International’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3M Buy
+815,000
New +$19.1M 0.01% 491
2020
Q1
Sell
-500
Closed -$17K 813
2019
Q4
$17K Buy
+500
New +$18.1K ﹤0.01% 731
2019
Q3
Sell
-126,594
Closed -$5.52M 891
2019
Q2
$5.52M Sell
126,594
-8,271
-6% -$354K 0.01% 522
2019
Q1
$5.76M Buy
134,865
+40,658
+43% +$1.82M 0.01% 499
2018
Q4
$4.22M Buy
+94,207
New +$4.94M 0.01% 525
2018
Q3
Sell
-56,528
Closed -$3.24M 926
2018
Q2
$3.24M Sell
56,528
-3,094
-5% -$163K ﹤0.01% 579
2018
Q1
$2.75M Buy
59,622
+12,798
+27% +$608K 0.01% 432
2017
Q4
$2.16M Buy
+46,824
New +$2.15M 0.01% 457

Other funds holding AVNS

Fidelity International's AVNS Position: Q2 2026 in Review

Fidelity International opened a new position in Avanos Medical (AVNS) in Q2 2026: 815,000 shares worth $20.3M. The stake represents 0.01% of the portfolio and ranks #491 among its holdings. This is a return to the name: Fidelity International previously reported a position in AVNS as recently as Q4 2019.

Fidelity International first reported a position in AVNS in Q4 2017 and has held it in 8 quarters since. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Fidelity International held 815,000 shares of Avanos Medical worth $20.3M as of Q2 2026.
  • Avanos Medical was a new Fidelity International position in Q2 2026.
  • Avanos Medical made up 0.01% of Fidelity International's portfolio in Q2 2026, its #491 holding.
  • Fidelity International first reported a position in Avanos Medical in Q4 2017 and has held it in 8 quarters since.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Fidelity International's 13F filing for Q2 2026, filed 13 Aug 2026.